Skip to main content
Equibles
ASMB logo

ASMB · Assembly Biosciences, Inc. · Metrics

Track ASMB — free

Use ASMB with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ASMB.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$29.80 -0.66 (-2.17%) At close · Sep 11
Russell 2000 member Rebalance outlook locked
Market Cap
$606.75M
Shares
20.36M

ASMB metrics

64 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$29.80
Market cap
$606.75M

Price action

20 metrics
Price change (1W)
-18.6%
Price change (30D)
-9.6%
Price change (3M)
+29.8%
Price change (6M)
+6.0%
Price change (YTD)
-12.4%
Price change (1Y)
+31.9%
Trailing year
Price change (5Y)
—
52-week high
$38.50
52-week low
$20.55
Change from 52-week high
-22.6%
Change from 52-week low
+45.0%
Annualized volatility
60.2%
Annualized volatility (3M)
63.7%
Beta
1.4
RSI (14D)
41.5
Price vs SMA 50
+0.7%
Price vs SMA 200
+2.0%
Avg volume (3M)
250,112
Relative volume
1.0
Average dollar volume
$7.39M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
20.36M

Valuation

12 metrics
P / E (TTM)
24.6
Trailing earnings · reciprocal yield 4.1%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
8.1×
reciprocal yield 12.3%
P / book
2.0
reciprocal yield 50.4%
FCF yield
-6.4%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
0.0%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-04-17

Profitability

9 metrics
Gross margin
—
Operating margin
-11.8%
Trailing 12 months
Net margin
-0.1%
Gross profit (TTM)
—
Operating profit (TTM)
−$8.80M
Net income (TTM)
−$42,000
Trailing 12 months
Diluted EPS (TTM)
$1.21
FCF margin
-51.5%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$13.04

Growth

11 metrics
Revenue growth YoY
+38.9%
Year over year
Net income growth YoY
—
Revenue (TTM)
$74.84M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+146.3%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
-1.8%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
0.0%
Return on assets
0.0%
Debt / equity
—
Current ratio
14.0
EBITDA (TTM)
−$8.69M
Free cash flow (TTM)
−$38.57M
Quick ratio
14.0
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$32.29M
Total assets
$330.83M
Total debt
$419,380

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$38.48M
Capital expenditures (TTM)
$85,000
R&D (TTM)
$63.65M
SG&A (TTM)
—
Stock compensation (TTM)
$6.66M
R&D / revenue
85.0%
Stock compensation / revenue
8.9%

Ownership (13F)

3 metrics
13F filers
93
13F filer change QoQ
+18
Institutional ownership
92.3%

Short interest

3 metrics
Short interest
10.4%
Latest settlement · 6.8 days to cover
Days to cover
6.8d
Short-squeeze score
68 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$674
Insider-sentiment score
61 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1426800 CUSIP 045396207 13F (30d) 50 filings 50 filers Visit website Investor relations